Stability-indicating micellar LC methods with time-programmed UV detection for determination of three oxicams in pharmaceuticals with direct injection of gel and suppositories

Journal of Liquid Chromatography and Related Technologies

Volumn 38, Issue 2, 2015, Pages 163-171

  El Shaheny, R N ^a  

^a Mansoura University 35516   (Egypt)

Author keywords

2 aminopyridine; formulations; MLC; oxicams; stability indicating

Indexed keywords

2-AMINOPYRIDINE; FORMULATIONS; MLC; OXICAMS; STABILITY-INDICATING;

2 AMINOPYRIDINE; LORNOXICAM; PIROXICAM; TENOXICAM;

ACCURACY; ARTICLE; COMPARATIVE STUDY; DRUG DEGRADATION; DRUG DETERMINATION; DRUG DOSAGE FORM; DRUG SPECIFICITY; GEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INJECTION; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MICELLAR LIQUID CHROMATOGRAPHY; MICROCAPSULE; PHARMACEUTICAL CARE; QUALITY CONTROL; SUPPOSITORY; TABLET; TIME; ULTRAVIOLET RADIATION;

EID: 84907898347     PISSN: 10826076     EISSN: 1520572X     Source Type: Journal    
DOI: 10.1080/10826076.2014.896814     Document Type: Article

References (46)

1. Brunton, L. L. Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 11th ed.; McGraw-Hill, Medical Publishing Division: New York, 2006; Electronic Version
2. Sweetman, S. C. Martindale: The Complete Drug Reference, 35th ed.; The Pharmaceutical Press: London, 2009, 77-78, 117-118, 128
3. The United States Pharmacopoeia 30th and The National formulary 25th; US Pharmacopeial Convention: Rockville, MD, 2007; Electronic Version
4. The British Pharmacopoeia; Her Majesty's Stationary Office: London, 2012; Electronic Version
5. Mândrescu, M.; Spac, A. F.; Dorneanu, V. Spectrophotometric Determination of Piroxicam Using Ferric Ferricyanide as Reagent. Rev. Med. Chir. Soc. Med. Nat. Iasi. 2009, 113, 268
6. El-Ries, M. A.; Mohamed, G.; Khalil, S.; El-Shall, M. Spectrophotometric and Potentiometric Determination of Piroxicam and Tenoxicam in Pharmaceutical Preparations. Chem. Pharm. Bull. 2003, 51, 6
7. Amin, A. S. Spectrophotometric Determination of Piroxicam and Tenoxicam in Pharmaceutical Formulations Using Alizarin. J. Pharm. Biomed. Anal. 2002, 29, 729
8. Nagaralli, B. S.; Seetharamappa, J.; Melwanki, M. B. Sensitive Spectrophotometric Methods for the Determination of Amoxycillin, Ciprofloxacin and Piroxicam in Pure and Pharmaceutical Formulations. J. Pharm. Biomed. Anal. 2002, 29, 859
9. Gowda, B. G.; Seetharamappa, J.; Melwanki, M. B. Indirect Spectrophotometric Determination of Propranolol Hydrochloride and Piroxicam in Pure and Pharmaceutical Formulations. Anal. Sci. 2002, 18, 671
10. Escandar, G. M. Spectrofluorimetric Determination of Piroxicam in the Presence and Absence of Beta-Cyclodextrin. Analyst 1999, 124, 587
11. Damiani, P. C.; Bearzotti, M.; Cabezón, M.; Olivieri, A. C. Spectrofluorometric Determination of Piroxicam. J. Pharm. Biomed. Anal. 1998, 17, 233
12. Ibrahim, H.; Boyer, A.; Bouajila, J.; Couderc, F.; Nepveu, F. Determination of Non-Steroidal Anti-Inflammatory Drugs in Pharmaceuticals and Human Serum by Dual-Mode Gradient HPLC and Fluorescence Detection. J. Chromatogr. B 2007, 857, 59
13. Panusa, A.; Multari, G.; Incarnato, G.; Gagliardi, L. High-Performance Liquid Chromatography Analysis of Anti- Inflammatory Pharmaceuticals with Ultraviolet and Electrospray- Mass Spectrometry Detection in Suspected Counterfeit Homeopathic Medicinal Products. J. Pharm. Biomed. Anal. 2007, 43, 1221
14. Sultan, M.; Stecher, G.; Stöggl, W. M.; Bakry, R.; Zaborski, P.; Huck, C. W.; El Kousy, N. M.; Bonn, G. K. Sample Pretreatment and Determination of Non Steroidal Anti-Inflammatory Drugs (NSAIDs) in Pharmaceutical Formulations and Biological Samples (Blood, Plasma, Erythrocytes) by HPLC-UV-MS and Micro- HPLC. Curr. Med. Chem. 2005, 12, 573
15. Yritia, M.; Parra, P.; Fernández, J. M.; Barbanoj, J. M. Piroxicam Quantitation in Human Plasma by High-Performance Liquid Chromatography with On- and Off-Line Solid-Phase Extraction. J. Chromatogr. A 1999, 846, 199
16. Gaudiano, M. C.; Valvo, L.; Bertocchi, P.; Manna, L. RP-HPLC Study of the Degradation of Diclofenac and Piroxicam in the Presence of Hydroxyl Radicals. J. Pharm. Biomed. Anal. 2003, 32, 151
17. Dadashzadeh, S.; Vali, A. M.; Rezagholi, N. LC Determination of PiroxicaminHuman Plasma. J. Pharm. Biomed. Anal. 2002, 28, 1201
18. Solangi, A. R.; Bhanger, M. I.; Memon, S. Q.; Khuhawar, M. Y.; Mallah, A. A Capillary Zone Electrophoretic Method for Simultaneous Determination of Seven Drugs in Pharmaceuticals and in Human Urine. J. AOAC Int. 2009, 92, 1382
19. Chen, Y. L.; Wu, S. M. Capillary Zone Electrophoresis for Simultaneous Determination of Seven Nonsteroidal Anti-Inflammatory Drugs in Pharmaceuticals. Anal. Bioanal. Chem. 2005, 38, 907
20. Fillet, M.; Bechet, I.; Piette, V.; Crommen, J. Separation of Nonsteroidal Anti-Inflammatory Drugs by Capillary Electrophoresis Using Nonaqueous Electrolytes. Electrophoresis 1999, 20, 1907
21. Donato, M. G.; Baeyens, W.; van den Bossche, W.; Sandra, P. The Determination of Non-Steroidal Anti-Inflammatory Drugs in Pharmaceuticals by Capillary Zone Electrophoresis and Micellar Electrokinetic Capillary Chromatography. J. Pharm. Biomed. Anal. 1994, 12, 21
22. Bai, H.; Nie, F.; Lu, J. Post-Chemiluminescence Phenomenon of NBS-Luminol Reactions and their Applications to Flow Injection Analysis of Piroxicam. Anal. Sci. 2007, 23, 1301
23. Al-Momani, I. F. Indirect Flow-Injection Spectrophotometric Determination of Meloxicam, Tenoxicam and Piroxicam in Pharmaceutical Formulations. Anal Sci. 2006, 22, 1611
24. Murillo Pulgarín, J. A.; Alanon Molina, A.; Boras, N. Determination of Piroxicam in Pharmaceutical Preparations by Continuous-flow Chemiluminescence. Anal. Methods. 2010, 2, 76
25. Abbaspour, A.; Mirzajani, R. Electrochemical Monitoring of Piroxicam in Different Pharmaceutical forms with Multi-Walled Carbon Nanotubes Paste Electrode. J. Pharm. Biomed. Anal. 2007, 44, 41
26. Taha, E. A.; Salama, N. N.; Fattah, Lel-S. Spectrofluorimetric and Spectrophotometric Stability-Indicating Methods for Determination of Some Oxicams Using 7-Chloro-4-Nitrobenz-2-Oxa-1,3- Diazole (NBD-Cl). Chem. Pharm. Bull. 2006, 54, 653
27. El Walily, A. F.; Blaih, S. M.; Barary, M. H.; El Sayed, M. A.; Abdine, H. H.; El Kersh, A. M. Simultaneous Determination of Tenoxicam and 2-Aminopyridine Using Derivative Spectrophotometry and High-Performance Liquid Chromatography. J. Pharm. Biomed. Anal. 1997, 15, 1923
28. Mohamed, H. A.; Wadood, H. M.; Farghaly, O. A. Potentiometric and Spectrofluorimetric Studies on Complexation of Tenoxicam with Some Metal Ions. J. Pharm. Biomed. Anal. 2002, 28, 819
29. Mason, J. L.; Hobbs, G. J. Simple Method for the Analysis of Tenoxicam in Human Plasma Using High-Performance Liquid Chromatography. J. Chromatogr. B 1995, 665, 410
30. Múnera-Jaramillo, M. I.; Botero-Garcés, S. Determination of Tenoxicam in Plasma by High-Performance Liquid Chromatography. J. Chromatogr. 1993, 616, 349
31. Taha, E. A.; Salama, N. A.; Abdel Fattah, L. E. Stability- Indicating Chromatographic Methods for the Determination of Some Oxicams. J. AOAC Int. 2004, 87, 366
32. García, M. S.; Sánchez-Pedreño, C.; Albero, M. I.; Gimenez, M. J. Flow-Injection Spectrophotometric Methods for the Determination of Tenoxicam. J. Pharm. Biomed. Anal. 1999, 21, 731
33. Jain, N.; Jain, R.; Sahu, V.; Sharma, H.; Jain, S.; Jain, D. K. Spectrophotometric Quantitative Estimation of Lornoxicam and Paracetamol in Bulk Drugs and Dosage Form. Der Pharm. Chem. 2010, 2, 165
34. Zhang, J.; Li, L.; Gao, Y.; Fan, W. Development and Validation of a Stability Indicating HPLC Method for the Analysis of Lornoxicam in Powder for Injection. Pak. J. Pharm. Sci. 2012, 25, 371
35. Modhave, D. T.; Handa, T.; Shah, R. P.; Singh, S. Stress Degradation Studies on Lornoxicam Using LC, LC-MS=TOF and LC-MS. J. Pharm. Biomed. Anal. 2011, 56, 538
36. Radhofer-Welte, S.; Dittrich, P. Determination of the Novel Non-Steroidal Anti-Inflammatory Drug Lornoxicam and its Main Metabolite in Plasma and Synovial Fluid. J. Chromatogr. B 1998, 707, 151
37. Suwa, T.; Urano, H.; Shinohara, Y.; Kokatsu, J. Simultaneous High-Performance Liquid Chromatographic Determination of Lornoxicam and Its 50-Hydroxy Metabolite in Human Plasma Using Electrochemical Detection. J. Chromatogr. 1993, 617, 105
38. Zhao, F.; Zhao, W. Investigation on the Micelle-Sensitized Ce(IV)- Lornoxicam-Rh B Chemiluminescence System and Its Application. J. Fluoresc. 2012, 22, 529
39. Hobbs, D. C.; Towney, T. M. Piroxicam Pharmacokinetics in Man: Aspirin and Antacid Interaction Studies. J. Clin. Pharm. 1979, 19, 270
40. Indo Gulf Group Company Catalogue. http://www.indogulfgroup. com/MSDS/2-Aminopyridine.pdf (accessed May 20, 2012
41. Esteve-Romero, J.; Carda-Broch, S.; Gil-Agustý', M.; Capella- Peiró , M. E.; Bose, D. Micellar Liquid Chromatography for the Determination of Drug Materials in Pharmaceutical Preparations and Biological Samples. Trends Anal. Chem. 2005, 24, 75
42. Martínez-Algaba, C.; Bermúdez-Saldaň a, J. M.; Villanueva- Camaň as, R. M.; Sagrado, S.; Medina-Hernández, M. J. Analysis of Pharmaceutical Preparations Containing Antihistamine Drugs by Micellar Liquid Chromatography. J. Pharm. Biomed Anal. 2006, 40, 312
43. Moffat, A. C. Clarkés Analysis of Drugs and Poisons, 3rd ed.; The Pharmaceutical Press: London, 2006; Electronic Version
44. Hansch, C.; Leo, A.; Hoekman, D. Exploring QSAR. Hydrophobic, Electronic, and Steric Constant: ACS Professional Reference Book; American Chemical Society: Washington, DC, 1995, p 12
45. ICH Harmonized Tripartite Guidelines, Validation of Analytical Procedures: Text and Methodology, International Conference on Harmonization, 2005. http://www.ich.org/products/guidelines/quality/article/quality-guidelines.html (accessed May 21, 2013
46. Miller, J. N.; Miller, J. C. Statistics and Chemometrics for Analytical Chemistry, 5th ed.; Pearson Education: Harlow, 2005, 39-73, 107-149, 256